InspireMD director buys 89,250 shares in market
InspireMD, Inc. director Ward Scott R. reported open-market purchases of company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
InspireMD, Inc. director Ward Scott R. reported open-market purchases of company common stock. He bought 15,995 shares on May 6 and 73,255 shares on May 7 at a weighted average price of $1.15 per share, with individual trade prices ranging from $1.13 to $1.15. Following these transactions, he directly holds 237,096 shares of InspireMD common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 73,255 | $1.15 | $84K |
| Purchase | Common Stock | 15,995 | $1.15 | $18K |
Footnotes (1)
- F1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
Form 4 regulatory
transaction code regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did InspireMD (NSPR) director Ward Scott R. report on this Form 4?
What are Ward Scott R.’s InspireMD (NSPR) holdings after these Form 4 transactions?
What price range did InspireMD (NSPR) trades cover in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.